InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by McGrath Yvonne, Vice-Présidente, Recherche et Développement et Directrice Scientifique. Officer active across 2 companies, notably iTeos Therapeutics, Inc.. Aggregated, 9 reports have been logged. History available since 17 May 2021. The latest transaction was disclosed on 7 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to McGrath Yvonne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
46,300 股Common StockSEC:0000950170-25-112235:0
15,300 股0Common StockSEC:0000950170-25-037513:0
31,000 股0Common StockSEC:0000950170-23-068903:0
10,000 股@ US$4.2413.4% 占其流量Common StockSEC:0001209191-22-015080:0
7,927 股@ US$4.2318.8% 占其流量Common StockSEC:0000899243-21-023000:0
7,927 股@ US$4.239.7% 占其流量Common StockSEC:0000899243-21-021779:0
7,604 股@ US$4.2317.9% 占其流量Common StockSEC:0000899243-21-021777:0
7,927 股@ US$4.2315.8% 占其流量Common StockSEC:0000899243-21-020733:0
7,926 股@ US$4.2315.8% 占其流量Common StockSEC:0000899243-21-019921:0
9 条申报中的 9 条
About McGrath Yvonne
Yvonne McGrath is VP, Research and Development and Chief Scientific Officer at iTeos Therapeutics, Inc. In this role, she oversees the company's research and development initiatives, ensuring innovation and advancement of scientific projects. Her expertise is essential to support the organization's mission.
